- Release Date: 29/05/24 09:03
- Summary: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
- Price Sensitive: Yes
- Download Document 2.8MB
- Forums
- ASX - By Stock
- COV
- Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COV (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.19M |
Open | High | Low | Value | Volume |
37.0¢ | 37.5¢ | 37.0¢ | $10.52K | 28.42K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17222 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17222 | 0.370 |
1 | 50000 | 0.360 |
1 | 14084 | 0.355 |
3 | 99225 | 0.350 |
4 | 34276 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 5000 | 1 |
0.390 | 84748 | 1 |
0.395 | 22010 | 1 |
0.405 | 31020 | 2 |
0.430 | 50000 | 1 |
Last trade - 14.39pm 30/08/2024 (20 minute delay) ? |
Featured News
COV (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online